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 Abstract 
 The microvasculature and macrovasculature undergo extensive, organ-specifi c perinatal maturation. Multiple studies show 
associations between low birth weight and subsequent cardiovascular dysfunction in adulthood, suggesting that extreme 
preterm birth interferes with this maturation process. Therefore, we designed PREMATCH (PREMATurity as predictor 
of Cardiovascular – renal Health) to phenotype the microcirculation and macrocirculation during childhood in former pre-
term infants. A well-characterized cohort of former extreme preterm birth survivors and gender- and age-matched controls 
(aged 8 – 13 years) will be investigated for microvascular and macrovascular structure and function. In addition to cognitive 
performance and anthropometrics, we will investigate (i) the microvascular structure and function by endothelial function 
(photoplethysmography), sublingual capillary glycocalyx function (sidestream dark fi eld imaging) and retinal structure 
(diameters of arterioles and venules); and (ii) the macrovascular phenotype by cardiac and renal ultrasound, repeated blood 
pressure measurements and arterial pulse-wave recordings. The PREMATCH study is unique in its design, and ongoing 
recruitment demonstrates excellent feasibility. The expectation is that the results of this study will identify risk factors dur-
ing childhood for subsequent cardiovascular – renal disease in the adult life of former preterm infants, while further analy-
sis on mediators in neonatal life of this cardiovascular – renal outcome may provide new information on perinatal risk 
factors. 
 Keywords:  Cardiovascular system ,  ELBW ,  extremely low birth weight infants ,  health policy and outcome research ,  macrocirculation , 
 microcirculation 
 Introduction 
 The cardiovascular system undergoes extensive mat-
uration throughout fetal, perinatal and pediatric life. 
Extreme preterm birth (i.e. extremely low birth 
weight, ELBW, birth weight    1000 g) interferes 
with normal development of the cardiovascular sys-
tem and other organs, resulting in suboptimal devel-
opment (1 – 4). There is evidence that extreme 
preterm birth increases the cardiovascular risk pro-
fi le in adulthood (5). In essence, this may be a refl ec-
tion of the Barker hypothesis, or fetal origin 
hypothesis (1), which states that a preterm infant, 
similarly to a growth-restricted newborn, does not 
reach its genetic potential for growth, leading to 
affected development of the microcirculation and 
macrocirculation. 
 Preterm birth interrupts the fetal conditions too 
early, potentially leading to maldevelopment of the 
microvascular structure and circulation in various 
organs, such as the retina [resulting in retinopathy 
of prematurity (6)] and the kidney [abnormal glom-
erulogenesis (7)]. Epidemiological observations fur-
ther confi rm that infants born preterm display a 
higher risk than full-term infants of developing 
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2 A. Raaijmakers et al. 
cardiovascular disease and chronic kidney disease 
during adulthood (1,2,8 – 10). 
 Rationale and design 
 Improved care for extreme preterm infants in neona-
tal intensive care units has led to the increased sur-
vival of these infants and an increased population of 
former preterm adults. Cardiovascular abnormalities 
following preterm birth include hypertension (10), 
but evidence concerning endothelial dysfunction is 
not consistent (11,12). 
 The PREMATurity as predictor of Cardiovascu-
lar – renal Health (PREMATCH) study aims to move 
beyond the state of the art by simultaneously assess-
ing both the microvascular and macrovascular struc-
ture and function in children (8 – 13 years old) in a 
case – control design. The index children are former 
ELBW infants, who each will be matched for gender 
and age with two controls. A particular strength of 
this study is that this ELBW cohort has been well 
characterized with respect to its perinatal aspects 
(13) (e.g. birth characteristics, growth pattern, per-
inatal drugs, respiratory support, Apgar scores, 
retinopathy). We will investigate the association of 
these perinatal aspects with current cardiovascular –
 renal health when the former preterm infants are 
currently 8 – 13 years old. Furthermore, a broader 
phenotyping regarding general health (level of cur-
rent education, grip strength, visual acuity) will be 
performed. In addition, we will examine routine 
clinical variables (i.e. anthropometrics, question-
naire). Finally, a cognitive performance test will 
complete the phenotyping. 
 Hypothesis and objectives 
 We hypothesize that former ELBW infants, com-
pared to controls following term birth, will have 
marked alterations in their microcirculatory and 
macrocirculatory structure and function, even at this 
young age. These changes, even if subtle, are prob-
ably forerunners of cardiovascular – renal disease in 
adulthood. In addition, confounders (e.g. neonatal 
nutrition, neonatal treatment) documented in early 
life may identify new approaches for timely preven-
tion (Figure 1). 
 Materials and methods 
 Participants 
 Our cohort consists of 140 extreme preterm birth 
survivors (ELBW, birth weight    1000 g) (13) who 
each will be matched for gender and age with two 
controls. Cases have the opportunity to bring an age- 
and gender-matched friend with them, who will be 
the fi rst control subject. A second control will be 
recruited in the neighborhood of the research center 
(Eksel, Belgium). 
 Ethics 
 The study will be conducted in accordance with the 
Helsinki Declaration for Investigation in Human 
Subjects. The local ethics committee of the 
University Hospitals Leuven (Belgium) approved 
the study protocol (June 2014, S56577). Based on 
good clinical practice guidance and national law, 
parents or custodians will provide written informed 
consent, while the child will have to give informed 
assent. The study is registered at ClinicalTrials.gov 
(NCT02147457). 
 Protocol 
 We will investigate the microvascular and macrovas-
cular structure and function and additional pheno-
typing (i.e. cognitive performance, anthropometrics, 
etc.) in children born preterm and healthy controls 
(defi ned as term gestation). Figure 1 schematically 
represents how PREMATCH intends to move from 
risk factors and measurement of phenotypes to rec-
ommendations for clinical care. 
 Microcirculatory phenotyping .  The microcirculation 
will be assessed functionally (endothelial function, 
glycocalyx measurements) and structurally (retinal 
imaging). 
  • Endothelial function will be assessed by 24 h 
urinary microalbumin excretion and by the 
digital pulse-wave amplitude hyperemic 
response, measured by photoplethysmography 
(PPG; Flomedi, Brussels, Belgium). The abso-
lute intraobserver variability in amplitude 
ratios in our hands is 0.062 for the average 
PPG and 0.072 for the PPG pulse; the 
interobserver variability is 3.29% in the aver-
age PPG pulse and 4.87% in the peak PPG 
pulse (14). 
  • Capillary glycocalyx and density will be meas-
ured in sublingual capillaries in two areas 
lateral to the frenulum and 3 – 4 cm anterior 
to the tongue base. To visualize these 
capillaries, we will use the Handheld Video 
Capillary Microscope (KK Research Tech-
nology, Honiton, UK), interfaced with a lap-
top computer running the GlycoCheck  ®  
software (GlycoCheck, Maastricht, The Neth-
erlands) (15). After adequate recording by 
sidestream dark-fi eld (SDF) imaging, the 
software calculates the perfused boundary 
region (PBR), which refl ects the thickness of 
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  Design and feasibility of PREMATCH  3
 Figure 1. Hypothesis and work plan. 
the endothelial glycocalyx, based on the 
assumption that loss of its integrity allows 
deeper penetration of red blood cells into the 
gel-like layer covering the endothelial lining. 
Higher PBR therefore indicates thinner gly-
cocalyx. The software also returns total and 
perfused capillary density in segments per 
square millimeter (15). 
  • Retinal imaging will be performed using a 
Canon Cr-DGi (Canon Co., Kyoto, Japan) 
non-mydriatic retinal visualization system. 
After accommodation to darkness, one image 
per eye will be obtained (16). Trained observ-
ers will identify individual arterioles and 
venules using a validated computer-assisted 
program, IVAN (Vasculo-matic Nicola, Oph-
thalmology and Visual Science, University of 
Wisconsin-Madison, USA) (17). This software 
combines the individual measurements into 
summary indices: central retinal arteriolar 
equivalent (CRAE), central retinal venular 
equivalent (CRVE) and arteriole-to-venule 
ratio (AVR), based on published validated for-
mulae (18 – 20). Our intraobserver and inter-
observer variability are 13.2% and 10.8% for 
CRAE, 8.4% and 9.9% for CRVE, and 9.0% 
and 14.6% for AVR, respectively (16). In addi-
tion, we will investigate  visual acuity (clearness 
of vision, spatial resolution of the visual 
processing system) using the non-invasive 
adapted Snellen charts (Medical Workshop, 
Groningen, The Netherlands), with and 
without visual aids. 
 Macrocirculatory phenotyping .  Similarly to the micro-
circulation, the macrocirculation will be assessed 
structurally (echocardiography, renal ultrasound and 
ultrasound of the carotid artery) and functionally 
(central hemodynamics, blood pressure). 
 Two experienced sonographers will perform a  •
detailed  echocardiographic examination in all 
children, using a Vivid E9 device (GE Vingmed, 
Horten, Norway), interfaced with a 2.5 – 3.5 
MHz phased-array probe. The digitally stored 
images will be analyzed with EchoPac soft-
ware (GE Vingmed). The acquisitive and 
offl ine analysis of the M-mode, two-dimen-
sional tissue Doppler and left ventricular 
images will be carried out according to the 
recommendations of the American Society of 
Echocardiography (21). Because of matura-
tional effects and growth characteristics,  Z - 
scores will be calculated according to pub-
lished reference values (22). 
  • Renal anatomy will be assessed by two-dimen-
sional ultrasound imaging (Vivid E9 interfaced 
with a 2.4 – 10 MHz linear array probe) and 
renal arterial Doppler blood fl ow measure-
ments. Again, ultrasound measurements are 
dependent on age and more importantly 
length, so  Z -scores will be used to compare our 
children to their controls and to the general 
child population according to published refer-
ence values (23). 
 Based on imaging of the common carotid  •
arteries by ultrasound, we will derive the  carotid 
artery diameter, distension and intima – media 
thickness . Subsequently, carotid distensibility 
(103/kPa), compliance (mm ² /kPa) and the 
Young ’ s elastic modulus will be calculated. 
  • Central hemodynamics will be calculated from 
peripheral arterial pulse-wave recordings. 
Pulse waves will be recorded at the carotid, 
radial and femoral arteries, by local application 
tonometry (SPC-301 micromanometer; Mil-
lar Instruments, Houston, TX, USA). From 
these recordings, the aortic pulse wave can be 
reconstructed by means of a validated general-
ized transfer function (SphygmoCor  ®  , version 
7.1; AtCor, Sydney, Australia) and the central 
blood pressure and the systolic augmentation 
index can be calculated. Finally, the pulse-
wave recording at three different sites will 
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4 A. Raaijmakers et al. 
allow us to calculate the carotid-to-femoral 
and carotid-to-radial pulse-wave velocities. 
 During a home visit, the  • blood pressure will 
be measured by the auscultatory Korotkoff 
approach using a mercury-free device 
(UM-101A; A & D Medical San Jose, USA) 
after the participants have rested for 5 min 
in the sitting position. 
 Additional phenotyping .
  • Renal function (glomerular fi ltration rate) will 
be retrieved from the measurement of creatinine 
clearance and 24  h microalbuminuria (24 h urine 
collection) and cystatin C (particle-enhanced 
turbidimetric immunoassay, Integra 400 sys-
tem; Roche Diagnostics, Basel, Switzerland) in 
peripheral blood (serum). 
  • Body composition will be examined by trained 
staff using the Bodystat QuadScan 4000 (Bod-
ystat, Isle of Man, British Isles). This device 
applies scientifi cally validated principles of 
bioelectrical impedance (24,25) and provides 
detailed information on a large number of 
variables, including lean and fat-free mass, 
body-fat mass index, fat-free mass index and 
the distribution of total body water over the 
intracellular and extracellular space. 
  • Cognitive performance will be assessed using the 
Wechsler Non-Verbal test, Dutch version 
(Pearson, Amsterdam, The Netherlands). We 
will examine both matrix reasoning and spatial 
span. 
  • Body weight ,  muscle mass ,  fat mass ,  body mass 
index (BMI) and  resting metabolism will be 
examined using the Omron Karada Scan 
(HBF511; Omron, Kyoto, Japan). 
  • Puberty scores will be assessed using the Tanner 
scale (26,27). 
  • Waist, hip, head and neck circumference will be 
measured using a tape measure. The umbilicus 
will be used as a marker of waist circumference. 
The greater trochanter will be used as a land-
mark for the hip circumference. Head circum-
ference will be measured with a tape measure 
on the forehead and around the full circumfer-
ence of the head. Neck circumference will be 
measured just below the larynx (thyroid carti-
lage) and perpendicular to the long axis of the 
neck. The participant will be asked to look 
straight ahead. Care will be taken not to involve 
the shoulder/neck muscles (trapezius) in the 
measurement of the neck circumference.  Height 
and  span width will also be examined. For the 
span width, the participant stands with the 
back against a wall, spreading the arms while 
placing the fi ngertips of one hand against a bar. 
The length will be measured with a ruler. 
 The Jamar Hydraulic Hand Dynamometer  •
(Sammons Preston, Chicago, IL, USA) will be 
used to measure  handgrip strength according to 
the owner ’ s manual. After setting the adjusta-
ble handle to the desired spacing, the red peak-
hold needle will be set to zero. In a sitting 
position with the elbow fl exed at 90 ° and the 
forearm and wrist in a neutral position, the 
participant will be asked to squeeze with max-
imum strength. This procedure will be repeated 
three times. 
 A caliper will be used to measure   • triceps, sub-
scapular and suprailiac skinfolds (Harpenden 
Skinfold Caliper; John Bull, Bedfordshire, 
UK). This caliper will provide a constant pres-
sure. Measurements will be read after 3 s to 
two decimal places. 
 Parents will be asked to complete a   • question-
naire regarding the health, educational level 
and medication use of their child. In addition, 
parents will be asked for their familial medical 
history, their educational level and BMI, and 
environmental factors concerning the child 
(e.g. smoking in the vicinity of the child). 
 Children will be asked to collect   • 24  h urine 
samples (volume, electrolytes, creatinine, micro-
albumin, aldosterone) and to provide a  blood 
sample . Routine analysis and storage for mark-
ers of metabolic stress (e.g. interleukin-6, high-
sensitivity C-reactive protein) will be performed. 
Blood sampling will be performed after fi xa-
tion of a Rapydan  ®  patch (70 mg lidocaine/
70 mg tetracaine; Eurocept, Ankeveen, The 
Netherlands) to minimize discomfort. In addi-
tion, we will ask parents for additional consent 
concerning hereditary studies (blood sample 
of parents for DNA to study known cardiovas-
cular risk genes) to see whether the differences 
between cases and controls are due to their 
gestational age (ELBW, control) or could have 
a genetic origin. 
 GPS coordinates of   • residence will be measured, 
and meteorological data and data on airborne 
pollutants and fi ne particulates will be col-
lected from the appropriate sources. 
 Database construction and statistical analysis 
 For database management and statistical analysis, we 
will use the SAS and SPSS system (two-tailed sig-
nifi cance level    0.05). Means, proportions and 
Kaplan – Meier survival function estimates will be 
compared using the large-sample  Z test, analysis of 
variance (ANOVA), Fisher ’ s exact test or the log-
rank test. If required, the distribution of variables will 
be normalized by appropriate transformation. Meth-
ods will also include multivariable adjusted linear 
and logistic regression analysis for cross-sectional 
data, and linear regression and proportional hazards 
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  Design and feasibility of PREMATCH  5
regression for longitudinal data. Stepwise regression 
procedures ( p value for entry and removal set at 
0.15) will be applied to identify potential important 
covariables. We will search for optimized discrimina-
tion limits for predictive baseline factors by maximiz-
ing Youden ’ s index. In addition, we will assess 
improvement in predictor variables, beyond what is 
currently known, by computing the integrated dis-
crimination improvement and the net reclassifi cation 
improvement (28,29). 
 Data from questionnaires will be collected online, 
preferably through computer-assisted self-interviewing 
(CASI) or computer-assisted telephone interviewing 
(CATI) before scheduled home visits, or computer-
assisted personal interviewing (CAPI) during home 
visits, using MOTUS software (designed by the 
Research Group TOR, Sociology Department, Vrije 
Universiteit Brussel, Belgium, www.prematch.be). 
 Results 
 To prove feasibility, a pilot study started in October 
2014 and was completed in December 2014. Sixteen 
former preterm infants were invited. Only one child 
declined participation, and three preferred to par-
ticipate in a later phase of the study. Three children 
were not yet matched to a control. In total, 12 cases 
and nine controls were fully investigated. The current 
 Figure 2. Flowchart of pilot and study design. ELBW, extremely 
low birth weight. 
 Table I. Characteristics of participants in the pilot study. 
Characteristic
Index 
participants
( N    12)
Control 
participants
( N    9)
Overall 
( N    21)
Gender (male/female) 5/7 5/4 10/11
Age (years) 11.5    1.2 11.3    1.3 11.4    1.2
Body weight (kg) 39    12 41    7 40    10
Muscle mass (%) 34    3 32    7 33    5
Fat mass (%) 19    9 22    7 20    8
BMI (kg/m ² ) 19    4 19    2 19    3
Waist circumference (cm) 66    9 68    10 67    9
Hip circumference (cm) 77    12 78    8 77    10
Body height (cm) 146    8 146    9 146    8
Skin folds (mm)
Upper arm 1.4    0.6 1.2    0.4 1.3    0.5
Subscapular 0.9    0.5 0.9    0.6 0.9    0.5
Suprailiac 0.9    0.5 0.8    0.4 0.8    0.5
 Data are shown as  n / n or mean   SD. 
 BMI, body mass index. 
 Table II. Phenotyping of participants in the pilot study. 
Phenotyping
Index 
participants
Control 
participants Overall
Microvascular structure and function
Endothelial function (Flomedi)
Baseline pulse amplitude, hyperemic fi nger 0.50    0.20 0.52    0.24 0.51    0.22
Control pulse amplitude, control fi nger 0.44    0.28 0.38    0.14 0.41    0.23
Sublingual capillaries (GlycoCheck)
Total capillary density (no./mm ² ) 538    75 548    83 542    79
Perfused capillary density (no./mm ² ) 303    62 290    63 298    61
Perfused boundary region ( μ m) 1.94    0.24 1.88    0.33 1.91    0.33
Retinal imaging
Central retinal arteriolar equivalent ( μ m) 147.8    9.1 157.4    11.4 151.9    11.0
Central retinal venular equivalent ( μ m) 218.1    10.3 228.0    12.3 222.3    12.0
Arteriole-to-venule ratio 0.68    0.05 0.69    0.07 0.69    0.06
Macrovascular structure and function
Ultrasound heart
Left ventricular mass (g) 75.6    15.9 86.2    7.8 80.1    13.9
Left ventricular mass ( Z -score)  – 1.37    1.21  – 0.69    0.75  – 1.08    1.07
Macrovascular function (SphygmoCor)
Carotid – femoral PWV (m/s) 4.13    1.34 4.19    0.65 4.16    1.06
Central systolic blood pressure (mmHg) 91.9    6.9 87.9    7.6 89.9    7.3
Central diastolic blood pressure (mmHg) 64.3    4.5 64.7    7.0 64.5    5.7
Blood pressure (mmHg) 114/71    11/9 112/74    8/6 114/73    10/8
 Data are shown as mean   SD. 
 PWV, pulse-wave velocity. 
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6 A. Raaijmakers et al. 
participation rate of the former preterm infants was 
75%. Figure 2 shows a fl owchart of PREMATCH. 
 The characteristics of the patients are summa-
rized in Table I. Basic results of microcirculation and 
macrocirculation and general investigations are sum-
marized in Table II. Statistical analysis was not per-
formed owing to the low numbers and the goal of 
this article (showing feasibility and study design). 
These results show that the phenotyping was toler-
ated and data collection was feasible in all examined 
patients. A survey of the pilot children revealed no 
major discomforts reported in examining the chil-
dren (Table III). The response rate of the question-
naire was 63%. In addition, parents reported high 
acceptability of the efforts requested (24 h urine col-
lection, traveling to the research center) (Table III). 
 Discussion 
 A cohort of 140 former preterm infants will be char-
acterized at the age of 8 – 13 years in a case – control 
design and the data will be related to those collected 
during the postnatal period. This additional retro-
spective cohort analysis adds a risk analysis in former 
preterm infants in reference to the control popula-
tion. We will investigate perinatal risk factors such as 
the use of ibuprofen, ventilation days and intraven-
tricular hemorrhage. In addition, we have collected 
information about the pregnancy [pre-eclampsia, 
tocolysis, lung maturation  in utero , premature rup-
ture of membranes (13)] and these data can add 
further value to the risk analysis. If applicable, we will 
include data on the placental pathology. The pheno-
types of interest in the case – control study include the 
microcirculatory and macrocirculatory and cardiac 
structure and function, endothelial function and 
renal anatomy and function during childhood. 
The expectation is that the results of this study will 
identify and quantify risk factors for cardiovascular –
 renal disease in former preterm infants compared to 
control children, while we can also map early risk 
factors for cardiovascular – renal disease in adult life 
and pave the way for better informed prevention of 
these complications. As preterm infants are more 
often surviving the postnatal period, the long-term 
outcome and secondary prevention become of 
extreme importance. The current cohorts of former 
preterm infants do not undergo investigation of both 
microvasculature and macrovasculature, and adult 
studies show that this is of utmost importance 
(30,31). The PREMATCH study is unique in its 
design, and ongoing recruitment demonstrates excel-
lent feasibility. 
 If we compare our cohort of former preterm infants 
to cohorts reported in the literature, there are some 
important methodological differences related to inclu-
sion criteria (birth weight) and assessments made 
(both microvasculature and microvasculature). We did 
not discriminate upon gestational age of the former 
preterm infant, but we did investigate children with 
ELBW (   1000 g), whereas, for example, the EPICure 
cohort (32) studies included infants in between 22 and 
26 weeks of gestational age, independent of birth 
weight. As a consequence, PREMATCH will have a 
larger number of children small for gestational age, 
owing to the study design, but will therefore have an 
excellent study design to investigate the prenatal and 
postnatal growth restriction seen in premature infants, 
refl ecting the Barker hypothesis (i.e. growth restric-
tion). The EPIPAGE cohort (Etude Epid é miologique 
sur les Petits Ages Gestationnels) (33) and POPS 
cohort (Project On Preterm and Small-for-gestation-
al-age infants) (34) consist of a broader mixture of 
gestational ages (22 – 32 weeks gestational age). 
 Besides differences in inclusion criteria, we aim 
to address aspects of the microvasculature and micro-
vasculature that have not yet been systematically 
documented in such a specifi c cohort of ELBW 
infants. The EPICure cohort in the UK mainly 
focuses on neurocognitive outcome and lung func-
tion (35 – 37), while the EPIPAGE cohort shows com-
prehensive data collection on neurocognitive outcome 
and infectious characteristics (38,39). Whereas the 
fi rst cohorts of preterm infants are now adults [POPS 
cohort, The Netherlands (34)] and those studies 
mainly focus on neurocognitive outcome and endo-
crinological disturbances (40,41), we are trying to 
fi nd early markers of cardiovascular dysfunction and 
to focus on long-term health in an era after major 
improvements in neonatal intensive care. Finally, the 
POPS study also provided evidence of microalbu-
minuria in young adulthood (mean age at evaluation 
19 years) after former preterm birth (42). 
 Different aspects of long-term outcome and the 
consequences of prematurity should be evaluated. 
Neurocognitive outcome remains the most studied 
object in former preterm infants (37,38,41,43 – 47). 
While other cohorts also focus on lung function (36), 
 Table III. Survey of discomfort and participation efforts in the 
pilot study. 
Question Overall a 
Overall clarity of explanation for children 4.4    0.6
Letter to child 4.2    0.4
Physician during home visit for children 4.8    0.5
Researchers in examination center for children 4.3    0.9
Clarity of explanation for parents 4.7    0.6
Letter to parents 4.7    0.5
Physician during home visit for parent 4.7    0.5
Researchers in examination center for parent 4.6    0.7
Children ’ s reported discomfort for survey 4.4    0.7
Reported participation effort for parents 4.0    1.1
Parents willingness to participate in further studies 4.7    0.5
Children’s willingness to participate in further studies 4.4    0.7
 Data are shown as mean   SD. 
 a Score: maximum 5 (fully agree, i.e. clear explanation, no 
discomfort, no effort, willing to participate again) to 1 (fully 
disagree, i.e. unclear explanation, discomfort, a lot of effort, not 
willing to participate again). 
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  Design and feasibility of PREMATCH  7
renal function (9) or cardiovascular risk, e.g. blood 
pressure (4,48) or intima media thickness (49), we 
will try to investigate simultaneously microvascular 
and macrovascular changes and explore the interac-
tions between risk factors and early biomarkers. A 
specifi c strength of this study is that the preterm 
cohort and their mothers have already been well 
characterized in the perinatal period (13). 
 Such long-term outcome studies are hampered by 
the challenges relating to technical investigations in 
children, including feasibility and validity. For exam-
ple, endothelial function measured in children can be 
diffi cult and results can be confusing. Measuring 
endothelial function before and after transdermal 
acetylcholine revealed no signifi cant differences in 
children born preterm in comparison to a healthy 
control population (11). This may be due to the lack 
of power ( n    39), because the results seem not to be 
consistent (50). The most common uncertainties in 
measuring endothelial function in a non-invasive way 
are the local, environmental and other factors that 
can modulate the measured shear stress. For exam-
ple, younger age can infl uence reactive hyperemia 
(51). The same group showed that fl ow-mediated 
dilatation is less vulnerable to such infl uences (51). 
In addition, the growth pattern after birth can have 
an infl uence on the endothelial function (52), but 
since we have a well-characterized cohort, we can 
correct for such infl uences as well. Another example 
is the measurement of the glycocalyx by SDF or 
orthogonal polarization spectral (OPS) imaging. 
Both techniques have comparable properties; SDF is 
the modifi ed version of the OPS (53). It has been 
shown that SDF is a feasible microperfusion marker 
in healthy adults (15). In children with type 1 diabe-
tes mellitus, these microvascular alterations can be 
detected early and more specifi cally, before apparent 
vascular complications (54). Although this may be an 
acquired alteration in these children instead of a 
structural problem in former preterm infants, these 
results at least show the feasibility of detecting alter-
ations before clinical complications. In addition, 
former preterm infants have an increased risk of car-
diovascular complications and, as the Barker hypoth-
esis suggests (1), this risk may be attenuated by the 
presence of impaired glucose tolerance. The last 
example is retinal imaging, were there is already 
increasing evidence that these images can predict car-
diovascular risk in specifi c subpopulations of children 
(55 – 58). It has been shown that there is an associa-
tion with BMI and weight (56), type 1 diabetes in 
children (55) and blood pressure (57,59). In addi-
tion, there is evidence that low birth weight is associ-
ated with signifi cant changes in the microvasculature 
of the retina (58,60). The strength of PREMATCH 
is that microvascular data are combined with macro-
vascular data and additional phenotyping (i.e. anthro-
pometrics, cognitive performance) to obtain a grip 
on risk factors and confounders of ELBW. In addi-
tion, we showed excellent feasibility, with no discom-
fort reported or objectifi ed (Table III). 
 To analyze our data, we will use  Z -scores when-
ever possible. A  Z -score is a standard deviation score 
of a measured value (e.g. kidney size) as a distance 
between the child ’ s value and the expected value (we 
will use published reference data for children if pos-
sible), with a mean of zero and a standard deviation 
of 1. Since reference data are not routinely available 
for the experimental measurements of microvascular 
and macrovascular function, we will generate a larger 
group of control children to create reference data to 
calculate  Z -scores for further studies. We are using 
 Z -scores because of their major advantages, com-
pared to percentiles for example, in that these  Z - 
scores refl ect the reference distribution and are stan-
dardized and thus comparable across age, gender 
and anthropometric measurements. For former pre-
term infants, we can also quantify the distribution at 
the end of the spectrum. Another advantage is that 
we can analyze  Z -scores as a continuous variable. 
 Although our study may be considered extensive 
and invasive, and consequently ambitious, we have 
shown in a pilot study an excellent feasibility and 
participation rate (at least 75%). In case of a lower 
participation rate in the sequel to the study, or mid-
term analysis revealing larger sample size calcula-
tions, we will consider pooling our cohort with 
neonatal intensive care units with which we are in 
collaboration (61). 
 Since our cohort has been characterized in detail 
in the postnatal period (13), potential confounders 
of preterm birth can be subcategorized and analyzed, 
and we may be able not only to detect differences 
between cases and controls, but also to point out risk 
factors in the perinatal period. Our ultimate goal is 
to improve guidelines for neonatal care. 
 Finally, pooling of cardiovascular phenotypic data 
in children with other cohorts may provide opportu-
nities for additional prediction model development, 
validation and subsequent secondary preventive 
strategies (Figure 1). 
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